Antibody drug conjugate programs (ADCs) are growing fast in oncology, combining selectivity with high potency.
You might say PFAS just won’t go away. They’ve been linked to health concerns, including cancer, thyroid disease, liver damage, fertility problems, and immune system disorders, as well as increased ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results